Agenus Makes Senior Regulatory and Clinical Appointments

September 12, 2022

https://www.globenewswire.com/news-release/2022/09/12/2514057/8060/en/Agenus-Makes-Senior-Regulatory-and-Clinical-Appointments.html

LEXINGTON, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) — Agenus (NASDAQ:AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate the immune response to cancers and infections, today announced the appointment of Patricia Carlos as Chief Regulatory, Quality, and Safety Officer; Todd Yancey, MD as Global Clinical Development, Medical Affairs and Commercial Development Advisor.

Read more at globenewswire.com

Related news for (AGEN)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.